French immunotherapy biotech TxCell, backed by Auriga Partners and Seventure Partners among others, has raised €16.2m in its IPO on the Euronext Paris.
Opportunities for growth expected to come from increasing demand for point-of-sale products
CareWorks is Advanced's first acquistion following the investment from BC Partners
Healthcare and digital tech vehicles will each target 12-15 companies with €10m tickets
Deal is Main Capital's third acquisition in the Dutch financial administrative software space